A lot more Americans are about to start taking a GLP-1 drug About 12 percent of Americans said in an August 2025 survey that they had taken a GLP-1 drug equivalent to more than 40 million people
(2006) in their study Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study, naltrexone combined with medical management resulted in a 20% reduction in the risk of heavy drinking compared to placebo, with adherence rates ranging from 50.0% to 72.6%, depending on genetic factors
G., Haq, R., Nishimura, E
While a bottle of pills might seem cheaper upfront, the low absorption rate means you're often getting very little of what you pay for
Acts on the brain's appetite-regulating centers to reduce hunger
7vy), linking astrocytic GABA dysregulation with impaired neurovascular coupling